KCNA3potassium voltage-gated channel subfamily A member 3
Autism Reports / Total Reports
2 / 2Rare Variants / Common Variants
14 / 0Aliases
-Associated Syndromes
-Chromosome Band
1p13.3Associated Disorders
-Relevance to Autism
Soldovieri et al., 2023 described 14 individuals carrying de novo missense variants in the KCNA3 gene, most of whom presented with a developmental and epileptic encephalopathy characterized by speech delay with or without motor delay, intellectual disability, epilepsy, and autism spectrum disorder; functional analysis of Kv1.3 channels carrying each missense variant revealed heterogeneous functional changes, ranging from loss-of-function effects with or without dominant negative effects to mixed loss- and gain-of-function effects. A de novo nonsense variant in the KCNA3 gene had previously been reported in an ASD proband from the SPARK cohort (Zhou et al., 2022).
Molecular Function
Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shaker-related subfamily. This member contains six membrane-spanning domains with a shaker-type repeat in the fourth segment. It belongs to the delayed rectifier class, members of which allow nerve cells to efficiently repolarize following an action potential. It plays an essential role in T-cell proliferation and activation.
External Links
SFARI Genomic Platforms
Reports related to KCNA3 (2 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Support | - | Zhou X et al. (2022) | Yes | - |
2 | Primary | - | Maria Virginia Soldovieri et al. (2024) | Yes | Epilepsy/seizures |
Rare Variants (14)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
c.436G>T | p.Glu146Ter | stop_gained | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.32C>G | p.Pro11Arg | missense_variant | De novo | - | - | 37964487 | Maria Virginia Soldovieri et al. (2024) | |
c.1292T>A | p.Ile431Asn | missense_variant | De novo | - | - | 37964487 | Maria Virginia Soldovieri et al. (2024) | |
c.1328C>T | p.Thr443Ile | missense_variant | De novo | - | - | 37964487 | Maria Virginia Soldovieri et al. (2024) | |
c.1378G>A | p.Val460Met | missense_variant | De novo | - | - | 37964487 | Maria Virginia Soldovieri et al. (2024) | |
c.1403G>T | p.Gly468Val | missense_variant | De novo | - | - | 37964487 | Maria Virginia Soldovieri et al. (2024) | |
c.1432G>A | p.Val478Met | missense_variant | De novo | - | - | 37964487 | Maria Virginia Soldovieri et al. (2024) | |
c.1574G>A | p.Ser525Asn | missense_variant | De novo | - | - | 37964487 | Maria Virginia Soldovieri et al. (2024) | |
c.1363A>G | p.Ile455Val | missense_variant | De novo | - | Simplex | 37964487 | Maria Virginia Soldovieri et al. (2024) | |
c.1402G>C | p.Gly468Arg | missense_variant | Unknown | - | Simplex | 37964487 | Maria Virginia Soldovieri et al. (2024) | |
c.1430C>A | p.Pro477His | missense_variant | Unknown | - | Simplex | 37964487 | Maria Virginia Soldovieri et al. (2024) | |
c.1070C>T | p.Ala357Val | missense_variant | De novo | - | Multiplex | 37964487 | Maria Virginia Soldovieri et al. (2024) | |
c.1081G>A | p.Ala361Thr | missense_variant | De novo | - | Multiplex | 37964487 | Maria Virginia Soldovieri et al. (2024) | |
c.1402_1403delinsTT | p.Gly468Phe | missense_variant | De novo | - | - | 37964487 | Maria Virginia Soldovieri et al. (2024) |
Common Variants
No common variants reported.
SFARI Gene score
Suggestive Evidence


Score Delta: Score remained at 3
criteria met
See SFARI Gene'scoring criteriaThe literature is replete with relatively small studies of candidate genes, using either common or rare variant approaches, which do not reach the criteria set out for categories 1 and 2. Genes that had two such lines of supporting evidence were placed in category 3, and those with one line of evidence were placed in category 4. Some additional lines of "accessory evidence" (indicated as "acc" in the score cards) could also boost a gene from category 4 to 3.
1/1/2024

Increased from to 3
Krishnan Probability Score
Score 0.49608378753754
Ranking 2692/25841 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.93991142055058
Ranking 14378/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score 0.057312310852454
Ranking 7045/20870 scored genes
[Show Scoring Methodology]